Gene interfered-ferroptosis therapy for cancers.

Area of Science:

• Biomedical Engineering
• Oncology
• Gene Therapy

Background:

• Cancer remains a significant health threat due to drug resistance and low treatment response rates.
• Targeted therapies are crucial for improving cancer treatment efficacy and reducing side effects.

Purpose of the Study:

• To develop a novel ferroptosis-based cancer therapy combining iron nanoparticles and gene interference.
• To selectively induce ferroptosis in cancer cells while minimizing impact on normal cells.

Main Methods:

• Selective knockdown of iron metabolic genes (FPN and LCN2) in cancer cells using Cas13a or microRNA under a NF-κB-specific promoter.
• Simultaneous treatment of cancer cells with iron nanoparticles to induce ferroptosis.
• In vivo studies using adeno-associated virus for gene transfer and iron nanoparticles in mice models.

Main Results:

• Significant ferroptosis was induced in a wide variety of cancer cells.
• The treatment showed minimal effect on normal cells, indicating cancer cell specificity.
• In vivo therapy demonstrated significant tumor growth inhibition and durable cure in mice.

Conclusions:

• Gene interference-enhanced ferroptosis is a promising strategy for cancer therapy.
• This approach offers a targeted and effective method for cancer treatment with potential for durable cures.